KR-505

N/A

Report date: 2025/03/17 15:02:18

Base Information

Drug NameKR-505
Drug Alias NameKR-505
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKernal Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKernal Biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A